{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:45:44Z","timestamp":1787741144800,"version":"build-2784847793"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The National Science Centre","award":["OPUS NCN2011\/03\/B\/NZ4\/00042"],"award-info":[{"award-number":["OPUS NCN2011\/03\/B\/NZ4\/00042"]}]},{"name":"Institute of Pharmacology"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.pnpbp.2015.07.005","type":"journal-article","created":{"date-parts":[[2015,7,16]],"date-time":"2015-07-16T21:48:55Z","timestamp":1437083335000},"page":"68-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats"],"prefix":"10.1016","volume":"64","author":[{"given":"Klaudia","family":"Kwiatkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Piotrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Rojewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioletta","family":"Makuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Jurga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Slusarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Trojan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Basta-Kaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Mika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2015.07.005_bb0005","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brainresrev.2008.12.002","article-title":"Chemokines and pain mechanisms","volume":"60","author":"Abbadie","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0010","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4049\/jimmunol.166.1.552","article-title":"The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat","volume":"166","author":"Ajuebor","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1749-6632.1999.tb07640.x","article-title":"Expression of chemokine receptors in the rat brain","volume":"876","author":"Bajetto","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0020","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb06672.x","article-title":"Partial opioids. Medications for the treatment of pain and drug abuse","volume":"909","author":"Bidlack","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0030","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.4049\/jimmunol.164.5.2650","article-title":"Role of CC chemokines (macrophage inflammatory protein-1 beta, monocyte chemoattractant protein-1, RANTES) in acute lung injury in rats","volume":"164","author":"Bless","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pain.2004.08.029","article-title":"Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells","volume":"112","author":"Brack","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0040","doi-asserted-by":"crossref","first-page":"7040","DOI":"10.1523\/JNEUROSCI.5171-04.2005","article-title":"Migration of perilesional microglia after focal brain injury and modulation by CC chemokine receptor 5: an in situ time-lapse confocal imaging study","volume":"25","author":"Carbonell","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0065","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejphar.2003.10.033","article-title":"Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor","volume":"483","author":"Chen","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0080","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1006\/bbrc.1995.2709","article-title":"Mu opioid receptor gene expression in immune cells","volume":"216","author":"Chuang","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2010.01.002","article-title":"Chemokines, neuronal\u2013glial interactions, and central processing of neuropathic pain","volume":"126","author":"Gao","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11481-006-9015-5","article-title":"Microglia biology in health and disease","volume":"1","author":"Garden","year":"2006","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/84209","article-title":"Chemokines and disease","volume":"2","author":"Gerard","year":"2001","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.pnpbp.2015.07.005_bb0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/glia.10161","article-title":"Microglia as a source and target of cytokines","volume":"40","author":"Hanisch","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0085","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/brain\/aws330","article-title":"Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain","volume":"136","author":"Imai","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/35093019","article-title":"Molecular mechanisms of nociception","volume":"413","author":"Julius","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0095","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.cdd.4402006","article-title":"HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection","volume":"14","author":"Kaul","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pain.2010.02.025","article-title":"Macrophage inflammatory protein-1alpha mediates the development of neuropathic pain following peripheral nerve injury through interleukin-1beta up-regulation","volume":"149","author":"Kiguchi","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coph.2011.10.007","article-title":"Chemokines and cytokines in neuroinflammation leading to neuropathic pain","volume":"12","author":"Kiguchi","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0014-2999(02)02052-6","article-title":"Buprenorphine alleviates neuropathic pain-like behaviors in rats after spinal cord and peripheral nerve injury","volume":"450","author":"Kouya","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2012.10.030","article-title":"Decreased pain responses of C\u2013C chemokine receptor 5 knockout mice to chemical or inflammatory stimuli","volume":"67","author":"Lee","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0120","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0149-2918(08)80048-3","article-title":"Maraviroc: a CCR5-receptor antagonist for the treatment of HIV-1 infection","volume":"30","author":"Lieberman-Blum","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpain.2012.09.015","article-title":"Peritoneal administration of Met-RANTES attenuates inflammatory and nociceptive responses in a murine neuropathic pain model","volume":"14","author":"Liou","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1471-4159.2011.07549.x","article-title":"Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120","volume":"120","author":"Lisi","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.neuropharm.2013.08.031","article-title":"Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats","volume":"75","author":"Makuch","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0140","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1523\/JNEUROSCI.4303-03.2004","article-title":"Neurons and astrocytes respond to prion infection by inducing microglia recruitment","volume":"24","author":"Marella","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0145","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/ALN.0000000000000190","article-title":"Chemokine (C\u2013C motif) receptor 5 is an important pathological regulator in the development and maintenance of neuropathic pain","volume":"120","author":"Matsushita","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2007.01.013","article-title":"Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain","volume":"560","author":"Mika","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbi.2008.07.005","article-title":"Attenuation of morphine tolerance by minocycline and pentoxifylline in naive and neuropathic mice","volume":"23","author":"Mika","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0160","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.neuroscience.2009.11.064","article-title":"Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain","volume":"165","author":"Mika","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejphar.2013.01.072","article-title":"Importance of glial activation in neuropathic pain","volume":"716","author":"Mika","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0170","doi-asserted-by":"crossref","first-page":"31305","DOI":"10.1074\/jbc.M001269200","article-title":"Morphine induces gene expression of CCR5 in human CEMx174 lymphocytes","volume":"275","author":"Miyagi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0175","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1523\/JNEUROSCI.21-14-05027.2001","article-title":"Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons","volume":"21","author":"Oh","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0180","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pain.2011.09.022","article-title":"Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks","volume":"153","author":"Padi","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0185","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/sj.bjp.0707263","article-title":"Chemokines and their receptors as potential targets for the treatment of asthma","volume":"151","author":"Palmqvist","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1517\/13543770802641346","article-title":"Chemokine receptor antagonists: part 1","volume":"19","author":"Pease","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0195","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1517\/13543770802641353","article-title":"Chemokine receptor antagonists: part 2","volume":"19","author":"Pease","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0200","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0006-8993(98)00292-3","article-title":"Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury","volume":"795","author":"Porreca","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-2999(01)01308-5","article-title":"Opioids in chronic pain","volume":"429","author":"Przewlocki","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0210","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.2174\/1381612054865055","article-title":"Opioids in neuropathic pain","volume":"11","author":"Przewlocki","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0304-3959(03)00138-6","article-title":"Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines","volume":"104","author":"Raghavendra","year":"2003","journal-title":"Pain"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0220","first-page":"1341","article-title":"Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection","volume":"151","author":"Rottman","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0225","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/j.1532-2149.2012.00146.x","article-title":"CC-chemokine ligand 4\/macrophage inflammatory protein-1\u03b2 participates in the induction of neuropathic pain after peripheral nerve injury","volume":"16","author":"Saika","year":"2012","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0230","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1124\/jpet.113.203984","article-title":"Effects of spinally administered bifunctional nociceptin\/orphanin FQ peptide receptor\/\u03bc-opioid receptor ligands in mouse models of neuropathic and inflammatory pain","volume":"346","author":"Sukhtankar","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0235","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/excr.2002.5638","article-title":"Interactions of opioid and chemokine receptors: oligomerization of mu, kappa, and delta with CCR5 on immune cells","volume":"280","author":"Suzuki","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0240","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1126\/science.288.5472.1765","article-title":"Neuronal plasticity: increasing the gain in pain","volume":"288","author":"Woolf","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0245","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0024-3205(00)00419-7","article-title":"The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients","volume":"66","author":"Wordliczek","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0250","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","article-title":"Chronic catheterization of the spinal subarachnoid space","volume":"17","author":"Yaksh","year":"1976","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0260","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1039\/c2ob06801j","article-title":"Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5","volume":"10","author":"Yuan","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0255","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1039\/c3md00080j","article-title":"A bivalent ligand targeting the putative mu opioid receptor and chemokine receptor CCR5 heterodimers: binding affinity versus functional activities","volume":"4","author":"Yuan","year":"2013","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0265","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/glia.20092","article-title":"A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells","volume":"49","author":"Zawadzka","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0270","doi-asserted-by":"crossref","first-page":"594","DOI":"10.4049\/jimmunol.173.1.594","article-title":"Proinflammatory chemokines, such as C\u2013C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons","volume":"173","author":"Zhang","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.pnpbp.2015.07.005_bb0275","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584615300130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584615300130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T05:47:52Z","timestamp":1566971272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584615300130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":55,"alternative-id":["S0278584615300130"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2015.07.005","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2015.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}